Daily Archives: November 1, 2022

Only one heavily pretreated patient presented a remarkable response to nivolumab and this patient was later found to harbour a MMR-deficient CRC. separate window ORR: Objective response rate; OS: Overall survival; MMR: Mismatch repair; NR: Not reached; NA: Not available. CHECKPOINT INHIBITORS RESULTS IN GI CANCERS Esophageal cancer Results from […]